Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs59211003 | chr5:1786940 | C/T | 6.4E-8 | 132 | 40.57 | 45.83 | 19.3 | KM Plot |
| TGCT | rs59233924 | chr14:71050660 | A/G | 1.47E-5 | 133 | 40.57 | 56.83 | 21.43 | KM Plot |
| TGCT | rs59268722 | chr4:47459281 | G/A | 0.000131 | 133 | 45.83 | 36.37 | 51.6 | KM Plot |
| TGCT | rs59377495 | chr10:1157019 | C/T | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs59396476 | chr6:28341972 | GA/G | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs59463904 | chr5:42559473 | T/C | 9.49E-5 | 132 | 38.2 | 63.68 | 20.23 | KM Plot |
| TGCT | rs59487085 | chr3:196198043 | C/G | 0.000143 | 130 | 35.4 | 41.27 | 43.6 | KM Plot |
| TGCT | rs59777512 | chr8:20033118 | G/A | 3.48E-12 | 132 | 42.27 | 41.47 | 20.6 | KM Plot |
| TGCT | rs598324 | chr13:21844915 | G/A | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs598754 | chr13:21845010 | C/A | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs59876630 | chr6:42626147 | TACTC/T | 2.46E-8 | 134 | 37.62 | 51.67 | 20.6 | KM Plot |
| TGCT | rs59928045 | chr6:15212678 | G/A | 7.25E-5 | 131 | 37.62 | 45.1 | NA | KM Plot |
| TGCT | rs59974236 | chr2:74109686 | A/T | 2.7E-7 | 129 | 40.57 | 95.37 | 22.83 | KM Plot |
| TGCT | rs60087663 | chr7:127745607 | A/C | 1.25E-13 | 133 | 45.47 | 36.23 | 17.1 | KM Plot |
| TGCT | rs60184496 | chr6:28330431 | A/G | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |